D2 and D4 dopamine receptor mRNA distribution in pyramidal neurons and GABAergic subpopulations in monkey prefrontal cortex: Implications for schizophrenia treatment

Neuroscience

Volumn 170, Issue 4, 2010, Pages 1133-1139

  de Almeida, J ^a   Mengod, G ^a  

^a INST D INVESTIGACIONS B   (Spain)

Author keywords

Calbindin; Co localization; Glutamatergic neurons; In situ hybridization; Parvalbumin

Indexed keywords

CALBINDIN; DOPAMINE 2 RECEPTOR; DOPAMINE 4 RECEPTOR; MESSENGER RNA; PARVALBUMIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; GABAERGIC SYSTEM; IN SITU HYBRIDIZATION; INTERNEURON; MONKEY; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PYRAMIDAL NERVE CELL; SCHIZOPHRENIA;

ANIMALS; CALCIUM-BINDING PROTEIN, VITAMIN D-DEPENDENT; GAMMA-AMINOBUTYRIC ACID; GLUTAMATE DECARBOXYLASE; GLUTAMIC ACID; IN SITU HYBRIDIZATION; INTERNEURONS; MACACA FASCICULARIS; PARVALBUMINS; PREFRONTAL CORTEX; PYRAMIDAL CELLS; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D4; RNA, MESSENGER; SCHIZOPHRENIA;

EID: 77957116049     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2010.08.025     Document Type: Article

References (51)

1. Ariano M.A., Wang J., Noblett K.L., Larson E.R., Sibley D.R. Cellular distribution of the rat D4 dopamine receptor protein in the CNS using anti-receptor antisera. Brain Res 1997, 752:26-34.
2. Beasley C.L., Zhang Z.J., Patten I., Reynolds G.P. Selective deficits in prefrontal cortical GABAergic neurons in schizophrenia defined by the presence of calcium-binding proteins. Biol Psychiatry 2002, 52:708-715.
3. Boeckler F., Russig H., Zhang W., Lober S., Schetz J., Hubner H., Ferger B., Gmeiner P., Feldon J. FAUC 213, a highly selective dopamine D4 receptor full antagonist, exhibits atypical antipsychotic properties in behavioural and neurochemical models of schizophrenia. Psychopharmacology (Berl) 2004, 175:7-17.
4. Conde F., Lund J.S., Jacobowitz D.M., Baimbridge K.G., Lewis D.A. Local circuit neurons immunoreactive for calretinin, calbindin D-28k or parvalbumin in monkey prefrontal cortex: distribution and morphology. J Comp Neurol 1994, 341:95-116.
5. Corrigan M.H., Gallen C.C., Bonura M.L., Merchant K.M. Effectiveness of the selective D4 antagonist sonepiprazole in schizophrenia: a placebo-controlled trial. Biol Psychiatry 2004, 55:445-451.
6. Daviss S.R., Lewis D.A. Local circuit neurons of the prefrontal cortex in schizophrenia: selective increase in the density of calbindin-immunoreactive neurons. Psychiatry Res 1995, 59:81-96.
7. Defagot M.C., Antonelli M.C. Autoradiographic localization of the putative D4 dopamine receptor in rat brain. Neurochem Res 1997, 22:401-407.
8. Defagot M.C., Falzone T.L., Low M.J., Grandy D.K., Rubinstein M., Antonelli M.C. Quantitative analysis of the dopamine D4 receptor in the mouse brain. J Neurosci Res 2000, 59:202-208.
9. Defagot M.C., Malchiodi E.L., Villar M.J., Antonelli M.C. Distribution of D4 dopamine receptor in rat brain with sequence-specific antibodies. Mol Brain Res 1997, 45:1-12.
10. DeFelipe J. Types of neurons, synaptic connections and chemical characteristics of cells immunoreactive for calbindin-D28K, parvalbumin and calretinin in the neocortex. J Chem Neuroanat 1997, 14:1-19.
11. De La G.R., Madras B.K. [(3)H]PNU-101958, a D(4) dopamine receptor probe, accumulates in prefrontal cortex and hippocampus of non-human primate brain. Synapse 2000, 37:232-244.
12. Goldman-Rakic P.S., Leranth C., Williams S.M., Mons N., Geffard M. Dopamine synaptic complex with pyramidal neurons in primate cerebral cortex. Proc Natl Acad Sci U S A 1989, 86:9015-9019.
13. Hashimoto T., Volk D.W., Eggan S.M., Mirnics K., Pierri J.N., Sun Z., Sampson A.R., Lewis D.A. Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia. J Neurosci 2003, 23:6315-6326.
14. Kapur S., Remington G. Atypical antipsychotics: new directions and new challenges in the treatment of schizophrenia. Annu Rev Med 2001, 52:503-517.
15. Khan Z.U., Gutierrez A., Martin R., Penafiel A., Rivera A., de la Calle A. Differential regional and cellular distribution of dopamine D2-like receptors: an immunocytochemical study of subtype-specific antibodies in rat and human brain. J Comp Neurol 1998, 402:353-371.
16. Khan Z.U., Koulen P., Rubinstein M., Grandy D.K., Goldman-Rakic P.S. An astroglia-linked dopamine D2-receptor action in prefrontal cortex. Proc Natl Acad Sci U S A 2001, 98:1964-1969.
17. Kramer M.S., Last B., Getson A., Reines S.A. The effects of a selective D4 dopamine receptor antagonist (L-745,870) in acutely psychotic inpatients with schizophrenia. D4 Dopamine Antagonist Group. Arch Gen Psychiatry 1997, 54:567-572.
18. Landry M., Holmberg K., Zhang X., Hokfelt T. Effect of axotomy on expression of NPY, galanin, and NPY Y1 and Y2 receptors in dorsal root ganglia and the superior cervical ganglion studied with double-labeling in situ hybridization and immunohistochemistry. Exp Neurol 2000, 162:361-384.
19. Lewis D.A., Gonzalez-Burgos G. Pathophysiologically based treatment interventions in schizophrenia. Nat Med 2006, 12:1016-1022.
20. Lidow M.S., Wang F., Cao Y., Goldman-Rakic P.S. Layer V neurons bear the majority of mRNAs encoding the five distinct dopamine receptor subtypes in the primate prefrontal cortex. Synapse 1998, 28:10-20.
21. Lisman J.E., Coyle J.T., Green R.W., Javitt D.C., Benes F.M., Heckers S., Grace A.A. Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia. Trends Neurosci 2008, 31:234-242.
22. Matsumoto M., Hidaka K., Tada S., Tasaki Y., Yamaguchi T. Full-length cDNA cloning and distribution of human dopamine D4 receptor. Brain Res Mol Brain Res 1995, 29:157-162.
23. Matsumoto M., Hidaka K., Tada S., Tasaki Y., Yamaguchi T. Low levels of mRNA for dopamine D4 receptor in human cerebral cortex and striatum. J Neurochem 1996, 66:915-919.
24. Mauger C., Sivan B., Brockhaus M., Fuchs S., Civelli O., Monsma F. Development and characterization of antibodies directed against the mouse D4 dopamine receptor. Eur J Neurosci 1998, 10:529-537.
25. Melchitzky D.S., Lewis D.A. Pyramidal neuron local axon terminals in monkey prefrontal cortex: differential targeting of subclasses of GABA neurons. Cereb Cortex 2003, 13:452-460.
26. Mrzljak L., Bergson C., Pappy M., Huff R., Levenson R., Goldman-Rakic P.S. Localization of dopamine D4 receptors in GABAergic neurons of the primate brain. Nature 1996, 381:245-248.
27. Mulcrone J., Kerwin R.W. The regional pattern of D4 gene expression in human brain. Neurosci Lett 1997, 234:147-150.
28. Murray A.M., Hyde T.M., Knable M.B., Herman M.M., Bigelow L.B., Carter J.M., Weinberger D.R., Kleinman J.E. Distribution of putative D4 dopamine receptors in postmortem striatum from patients with schizophrenia. J Neurosci 1995, 15:2186-2191.
29. Paspalas C.D., Goldman-Rakic P.S. Microdomains for dopamine volume neurotransmission in primate prefrontal cortex. J Neurosci 2004, 24:5292-5300.
30. Pompeiano M., Palacios J.M., Mengod G. Distribution and cellular localization of mRNA coding for 5-HT1A receptor in the rat brain: correlation with receptor binding. J Neurosci 1992, 12:440-453.
31. Primus R.J., Thurkauf A., Xu J., Yevich E., McInerney S., Shaw K., Tallman J.F., Gallagher D.W. II. Localization and characterization of dopamine D4 binding sites in rat and human brain by use of the novel, D4 receptor-selective ligand [3H]NGD 94-1. J Pharmacol Exp Ther 1997, 282:1020-1027.
32. Rajkowska G., O'Dwyer G., Teleki Z., Stockmeier C.A., Miguel-Hidalgo J.J. GABAergic neurons immunoreactive for calcium binding proteins are reduced in the prefrontal cortex in major depression. Neuropsychopharmacology 2007, 32:471-482.
33. Rivera A., Cuellar B., Giron F.J., Grandy D.K., de la Calle A., Moratalla R. Dopamine D4 receptors are heterogeneously distributed in the striosomes/matrix compartments of the striatum. J Neurochem 2002, 80:219-229.
34. Sakai T., Oshima A., Nozaki Y., Ida I., Haga C., Akiyama H., Nakazato Y., Mikuni M. Changes in density of calcium-binding-protein-immunoreactive GABAergic neurons in prefrontal cortex in schizophrenia and bipolar disorder. Neuropathology 2008, 28:143-150.
35. Santana N., Mengod G., Artigas F. Quantitative analysis of the expression of dopamine D1 and D2 receptors in pyramidal and GABAergic neurons of the rat prefrontal cortex. Cereb Cortex 2009, 19:849-860.
36. Schmitz G.G., Walter T., Seibl R., Kessler C. Nonradioactive labeling of oligonucleotides in vitro with the hapten digoxigenin by tailing with terminal transferase. Anal Biochem 1991, 192:222-231.
37. Seeman P., Corbett R., Van Tol H.H. Atypical neuroleptics have low affinity for dopamine D2 receptors or are selective for D4 receptors. Neuropsychopharmacology 1997, 16:93-110.
38. Seeman P., Guan H.C., Van Tol H.H. Schizophrenia: elevation of dopamine D4-like sites, using [3H]nemonapride and [125I]epidepride. Eur J Pharmacol 1995, 286:R3-R5.
39. Serrats J., Artigas F., Mengod G., Cortés R. GABAB receptor mRNA in the raphe nuclei: co-expression with serotonin transporter and glutamic acid decarboxylase. J Neurochem 2003, 84:743-752.
40. Sesack S.R., Snyder C.L., Lewis D.A. Axon terminals immunolabeled for dopamine or tyrosine hydroxylase synapse on GABA-immunoreactive dendrites in rat and monkey cortex. J Comp Neurol 1995, 363:264-280.
41. Staley J.K., Tamagnan G., Baldwin R.M., Fujita M., Al Tikriti M.S., Eshima L., Thornback J., Roe D., Lu L., Seibyl J.P., Innis R.B. SPECT imaging with the D(4) receptor antagonist L-750,667 in nonhuman primate brain. Nucl Med Biol 2000, 27:547-556.
42. Surmeier D.J., Song W.J., Yan Z. Coordinated expression of dopamine receptors in neostriatal medium spiny neurons. J Neurosci 1996, 16:6579-6591.
43. Suzuki T., Kobayashi K., Nagatsu T. Genomic structure and tissue distribution of the mouse dopamine D4 receptor. Neurosci Lett 1995, 199:69-72.
44. Tomiyama M., Palacios J.M., Cortés R., Vilaró M.T., Mengod G. Distribution of AMPA receptor subunit mRNAs in the human basal ganglia: an in situ hybridization study. Mol Brain Res 1997, 46:281-289.
45. Truffinet P., Tamminga C.A., Fabre L.F., Meltzer H.Y., Riviere M.E., Papillon-Downey C. Placebo-controlled study of the D4/5-HT2A antagonist fananserin in the treatment of schizophrenia. Am J Psychiatry 1999, 156:419-425.
46. Van Tol H.H., Bunzow J.R., Guan H.C., Sunahara R.K., Seeman P., Niznik H.B., Civelli O. Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine. Nature 1991, 350:610-614.
47. Vincent S.L., Khan Y., Benes F.M. Cellular distribution of dopamine D1 and D2 receptors in rat medial prefrontal cortex. J Neurosci 1993, 13:2551-2564.
48. Wedzony K., Chocyk A., Mackowiak M., Fijal K., Czyrak A. Cortical localization of dopamine D4 receptors in the rat brain-immunocytochemical study. J Physiol Pharmacol 2000, 51:205-221.
49. Williams G.V., Goldman-Rakic P.S. Modulation of memory fields by dopamine D1 receptors in prefrontal cortex. Nature 1995, 376:572-575.
50. Yuen E.Y., Yan Z. Dopamine D4 receptors regulate AMPA receptor trafficking and glutamatergic transmission in GABAergic interneurons of prefrontal cortex. J Neurosci 2009, 29:550-562.
51. Zaitsev A.V., Gonzalez-Burgos G., Povysheva N.V., Kroner S., Lewis D.A., Krimer L.S. Localization of calcium-binding proteins in physiologically and morphologically characterized interneurons of monkey dorsolateral prefrontal cortex. Cereb Cortex 2005, 15:1178-1186.